We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Involvement of Eukaryotic Translation Initiation Factor 4E (eIF4E) in Human Placental Implantation and in the Pathological Pregnancies: Preeclampsia and IUGR

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01179542
Recruitment Status : Withdrawn (recruiting problems)
First Posted : August 11, 2010
Last Update Posted : September 13, 2017
Sponsor:
Information provided by (Responsible Party):

Study Description
Brief Summary:
The involvement of eukaryotic translation initiation factor 4E (eIF4E) in human placental implantation and in the pathological pregnancies: preeclampsia and IUGR.

Condition or disease
Pregnancy Preeclampsia

Detailed Description:
4 groups

Study Design

Study Type : Observational
Actual Enrollment : 0 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: The Involvement of Eukaryotic Translation Initiation Factor 4E (eIF4E) in Human Placental Implantation and in the Pathological Pregnancies: Preeclampsia and IUGR.
Study Start Date : September 2010
Primary Completion Date : October 2012
Study Completion Date : October 2012

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Groups and Cohorts

Group/Cohort
first trimester
first trimester
third trimester
third trimester
prgnancies complicated with IUGR
prgnancies complicated with IUGR
preeclampsia
preeclampsia


Outcome Measures

Primary Outcome Measures :
  1. measure the Translation Initiation effect of experimental variables observational studies [ Time Frame: 2 years ]

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 50 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
Only the Placenta aftr delivery or abortion
Criteria

Inclusion Criteria:

  • post TOP or DELIVERY

Exclusion Criteria:

More Information

Responsible Party: Meir Medical Center
ClinicalTrials.gov Identifier: NCT01179542     History of Changes
Other Study ID Numbers: mmc10134-2010ctil
First Posted: August 11, 2010    Key Record Dates
Last Update Posted: September 13, 2017
Last Verified: August 2010

Keywords provided by Meir Medical Center:
iugr pet eIF4E Translation Initiation Factor
4E (eIF4E) in Human Placental Implantation and in the Pathological Pregnancies: Preeclampsia and IUGR

Additional relevant MeSH terms:
Pre-Eclampsia
Hypertension, Pregnancy-Induced
Pregnancy Complications